Showing results (1-10 of 147) with videos related to
Sort By:
Pageof 15
Cardiology|January 1, 1995
Short- and long-term prognostic implications of in-hospital postinfarction arrhythmias. DAVIT II Study GroupM Vaage-Nilsen, J F Hansen, K Mellemgaard, et al.Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 1, 1997
Treatment with verapamil and trandolapril in patients with congestive heart failure and myocardial infarction. The Danish Verapamil Infarction Trial (DAVIT Study Group)J F Hansen, L Hagerup, B Sigurd, et al.American Heart Journal|August 1, 1997
Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction TrialJ F Hansen, L Hagerup, B Sigurd, et al.International Journal of Cardiology|March 3, 1995
Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II)M Vaage-Nilsen, J F Hansen, K Mellemgaard, et al.The American Journal of Cardiology|March 15, 1997
Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study GroupJ F Hansen, L Hagerup, B Sigurd, et al.Acta Medica Scandinavica. Supplementum|January 1, 1984
Verapamil or propranolol in the treatment of stable angina pectoris of effortB Sigurd, J F HansenEuropean Heart Journal|June 1, 1988
Independent prognostic risk factors for patients referred because of suspected acute myocardial infarction without confirmed diagnosis. Prognosis after discharge in relation to medical history and non-invasive investigationsJ K Madsen, B L Thomsen, K Mellemgaard, et al.Journal of Cardiovascular Pharmacology|January 1, 1991
Effect of verapamil on ischemia and ventricular arrhythmias after an acute myocardial infarction: prognostic implications. The Danish Verapamil Infarction Trial II Study GroupM Vaage-Nilsen, V Rasmussen, J F Hansen, et al.Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1982
Verapamil and beta-adrenoceptor blockade in the treatment of stable angina pectorisJ F Hansen, C Grytter, S Thomsen, et al.British Journal of Clinical Pharmacology|April 1, 1979
Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exerciseN Clausen, T Damsgaard, K MellemgaardPageof 15